CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- 4/A Open-market buy Director bought 5,813,954 shares at $2.15 ($12,500,001)
- SC 13D/A Stake Beneficial Ownership Report
- 3 Insider Initial Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- 4 Open-market buy Director bought 5,813,954 shares at $2.15 ($12,500,001)
- 4 Open-market buy Director bought 25,000 shares at $2.15 ($53,750)
- 4 Open-market buy VP, CFO bought 6,500 shares at $2.15 ($13,975)
- 4 Open-market buy President and CEO bought 485,000 shares at $2.15 ($1,042,750)
- 4 Open-market buy EVP, CSO and CMO bought 10,000 shares at $2.15 ($21,500)
- 8-K Event Other events
- 424B1 Offering Prospectus
- 8-K Event Material agreement
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- 10-Q Report Quarterly Report
Page 32 of 50 · 1,000 filings